Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases

The survival of patients with head and neck squamous cancer with locoregional recurrence is short if salvage surgery or radiation cannot be performed. Systemic chemotherapy based on platinum salts and cetuximab produces only partial and transient responses. Immune checkpoint inhibitors (i.e., nivolu...

Descripción completa

Detalles Bibliográficos
Autores principales: Houessinon, Aline, Moreira, Aurélie, Bettoni, Jérèmie, Schoonaker, Marine, Sauzay, Chloé, Galmiche, Antoine, Coutte, Alexandre, Biet, Aurélie, Krzisch, Claude, Chauffert, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443634/
https://www.ncbi.nlm.nih.gov/pubmed/32884527
http://dx.doi.org/10.1159/000507986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443634/
https://www.ncbi.nlm.nih.gov/pubmed/32884527
http://dx.doi.org/10.1159/000507986

Ejemplares similares